GENIX enables comparative network analysis of single-cell RNA sequencing to reveal signatures of therapeutic interventions
- PMID: 38861988
- PMCID: PMC11228368
- DOI: 10.1016/j.crmeth.2024.100794
GENIX enables comparative network analysis of single-cell RNA sequencing to reveal signatures of therapeutic interventions
Abstract
Single-cell RNA sequencing (scRNA-seq) has transformed our understanding of cellular responses to perturbations such as therapeutic interventions and vaccines. Gene relevance to such perturbations is often assessed through differential expression analysis (DEA), which offers a one-dimensional view of the transcriptomic landscape. This method potentially overlooks genes with modest expression changes but profound downstream effects and is susceptible to false positives. We present GENIX (gene expression network importance examination), a computational framework that transcends DEA by constructing gene association networks and employing a network-based comparative model to identify topological signature genes. We benchmark GENIX using both synthetic and experimental datasets, including analysis of influenza vaccine-induced immune responses in peripheral blood mononuclear cells (PBMCs) from recovered COVID-19 patients. GENIX successfully emulates key characteristics of biological networks and reveals signature genes that are missed by classical DEA, thereby broadening the scope of target gene discovery in precision medicine.
Keywords: CP: systems biology; gene network association; gene program discovery; scRNA-seq; system biology; target identification.
Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests The authors are employees of Sanofi US.
Figures







References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous